相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Potential roles and targeted therapy of the CXCLs/CXCR2 axis in cancer and inflammatory diseases
Yuan Cheng et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)
Re-education of Tumor-Associated Macrophages by CXCR2 Blockade Drives Senescence and Tumor Inhibition in Advanced Prostate Cancer
Diletta Di Mitri et al.
CELL REPORTS (2019)
New CXCR1/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatments
Maeva Dufies et al.
THERANOSTICS (2019)
Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma
Timothy M. Nywening et al.
GUT (2018)
CXCR2 promotes breast cancer metastasis and chemoresistance via suppression of AKT1 and activation of COX2
Han Xu et al.
CANCER LETTERS (2018)
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
L. Gandhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Anti-PD-1/PD-L1 Therapy for Non-Small-Cell Lung Cancer: Toward Personalized Medicine and Combination Strategies
Hongshu Sui et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Tumor conditions induce bone marrow expansion of granulocytic, but not monocytic, immunosuppressive leukocytes with increased CXCR2 expression in mice
Zhen Bian et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2018)
CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer
H. Zhang et al.
ONCOGENE (2017)
Non-Small Cell Lung Cancer, Version 5.2017 Clinical Practice Guidelines in Oncology
David S. Ettinger et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab
Stefan Diem et al.
LUNG CANCER (2017)
Cisplatin selectively downregulated the frequency and immunoinhibitory function of myeloid-derived suppressor cells in a murine B16 melanoma model
Xiang Huang et al.
IMMUNOLOGIC RESEARCH (2016)
Type I IFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human
Lisa Andzinski et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression
Guocan Wang et al.
CANCER DISCOVERY (2016)
Cancer treatment and survivorship statistics, 2016
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma
Colin W. Steele et al.
CANCER CELL (2016)
The CXCL8-CXCR1/2 pathways in cancer
Qian Liu et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2016)
Repertaxin, an inhibitor of the chemokine receptors CXCR1 and CXCR2, inhibits malignant behavior of human gastric cancer MKN45 cells in vitro and in vivo and enhances efficacy of 5-fluorouracil
Junpu Wang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Thrombin inhibition and cisplatin block tumor progression in ovarian cancer by alleviating the immunosuppressive microenvironment
Eric T. Alexander et al.
ONCOTARGET (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
TGF-β Promotes Heterogeneity and Drug Resistance in Squamous Cell Carcinoma
Naoki Oshimori et al.
CELL (2015)
CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis
Muhammad Noman Khan et al.
Oncotarget (2015)
TGFβ Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and Metastasis
Panagiotis Papageorgis
JOURNAL OF ONCOLOGY (2015)
The Multifaceted Roles Neutrophils Play in the Tumor Microenvironment
Ronit Vogt Sionov et al.
CANCER MICROENVIRONMENT (2015)
The CXCL7/CXCR1/2 Axis Is a Key Driver in the Growth of Clear Cell Renal Cell Carcinoma
Renaud Grepin et al.
CANCER RESEARCH (2014)
Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer
Evgeniy B. Eruslanov et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy
Steven L. Highfill et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression
Inbal Mishalian et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
CXCR2 Expression in Tumor Cells Is a Poor Prognostic Factor and Promotes Invasion and Metastasis in Lung Adenocarcinoma
Pierre Saintigny et al.
CANCER RESEARCH (2013)
CXC Receptor 1 and 2 and Neutrophil Elastase Inhibitors Alter Radiation-induced Lung Disease in the Mouse
Jessica Fox et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Tumor-associated neutrophils: friend or foe?
Zvi G. Fridlender et al.
CARCINOGENESIS (2012)
Drug resistance and its significance for treatment decisions in non-small-cell lung cancer
E. Tsvetkova et al.
CURRENT ONCOLOGY (2012)
A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1
Janesh Pillay et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
The CXCR2 Antagonist, SCH-527123, Shows Antitumor Activity and Sensitizes Cells to Oxaliplatin in Preclinical Colon Cancer Models
Yan Ning et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer
Minu K. Srivastava et al.
PLOS ONE (2012)
Human pituitary tumor-transforming gene 1 overexpression reinforces oncogene-induced senescence through CXCR2/p21 signaling in breast cancer cells
Jhen-Wei Ruan et al.
BREAST CANCER RESEARCH (2012)
Tumor Entrained Neutrophils Inhibit Seeding in the Premetastatic Lung
Zvi Granot et al.
CANCER CELL (2011)
The expression and role of CXC chemokines in colorectal cancer
Hannelien Verbeke et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2011)
Preconditioning chemotherapy with paclitaxel and cisplatin enhances the antitumor activity of cytokine induced-killer cells in a murine lung carcinoma model
Xiang Huang et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Inhibition of neutrophil infiltration into A549 lung tumors in vitro and in vivo using a CXCR2-specific antagonist is associated with reduced tumor growth
Simon Tazzyman et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma
Hideaki Ijichi et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
New driver mutations in non-small-cell lung cancer
William Pao et al.
LANCET ONCOLOGY (2011)
CXCR2 Promotes Ovarian Cancer Growth through Dysregulated Cell Cycle, Diminished Apoptosis, and Enhanced Angiogenesis
Gong Yang et al.
CLINICAL CANCER RESEARCH (2010)
CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow
Kyle J. Eash et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: N1 versus N2 TAN
Zvi G. Fridlender et al.
CANCER CELL (2009)
A Role for CXCR2 in Senescence, but What about in Cancer?
Juan C. Acosta et al.
CANCER RESEARCH (2009)
The functional significance behind expressing two IL-8 receptor types on PMN
RoseMarie Stillie et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Increased invasion through basement membrane by CXCL7-transfected breast cells
Zhuo Tang et al.
AMERICAN JOURNAL OF SURGERY (2008)
Chemotherapy-Induced CXC-Chemokine/CXC-Chemokine Receptor Signaling in Metastatic Prostate Cancer Cells Confers Resistance to Oxaliplatin through Potentiation of Nuclear Factor-kappa B Transcription and Evasion of Apoptosis
Catherine Wilson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy
James E. Talmadge
CLINICAL CANCER RESEARCH (2007)
Oxidative burst of neutrophils against melanoma B16-F10
Morana Zivkovic et al.
CANCER LETTERS (2007)
Critical and opposing roles of the chemolkine receptors CXCR2 and CXCR3 in prostate tumor growth
Hui Shen et al.
PROSTATE (2006)
Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis
Moritz N. Wente et al.
CANCER LETTERS (2006)
Current concepts in bronchioloalveolar carcinoma biology
Dan J. Raz et al.
CLINICAL CANCER RESEARCH (2006)
TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance
DA Thomas et al.
CANCER CELL (2005)
Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer
MP Keane et al.
JOURNAL OF IMMUNOLOGY (2004)
The role of chemokines in melanoma tumor growth and metastasis
AS Payne et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Interleukin-8 and human cancer biology
KP Xie
CYTOKINE & GROWTH FACTOR REVIEWS (2001)
Polymorphonuclear neutrophils as accessory cells for T-cell activation:: major histocompatibility complex class II restricted antigen-dependent induction of T-cell proliferation
M Radsak et al.
IMMUNOLOGY (2000)
分享论文
